The DOI matches its Crossref record; 43 of the 47 references it cites were found in a registry or an index.
Microsatellite Instability and p53 Mutations Are Associated With Abnormal Expression of the MSH2 Gene in Adult Acute Leukemia
Abstract
Microsatellite instability (MSI) and p53 mutations have been reported to occur in a significant proportion of patients with therapy-related acute myeloid leukemia (AML). MSH2 is one of the genes involved in DNA mismatch repair to maintain fidelity of genomic replication, and defects of MSH2 are directly involved in MSI in hereditary nonpolyposis colorectal tumors and other human tumors. We have examined the expression of MSH2 protein by Western blotting in 43 adult leukemia samples, including 42 AML and 1 acute lymphoblastic leukemia (ALL) using the antibody MSH2 (Ab-1) (Calbiochem, La Jolla, CA). Abnormal expression of MSH2 protein was found in 14 of 43 (32.6%) cases; a control antibody to actin was always positive. Of the 14 patients that had abnormal expression of MSH2, 2 had therapy-related acute leukemia and 9 were elderly patients (>60 years of age). Expression of MSH2 mRNA was further examined by reverse transcriptase-polymerase chain reaction (RT-PCR). Deletion of MSH2 mRNA was found in 1 of 14 cases with deficient MSH2 protein expression. This group of patients was also screened for loss of heterozygosity (LOH) at the MSH2 locus using a panel 4 microsatellite markers (D2S367, D2S288, D2S391, and D2S2294). LOH was found in 5 of 11 cases examined. There was no evidence of LOH in 14 patients with normal MSH2 expression who were examined using the same markers. Functional evidence for defective DNA mismatch repair in leukemic cells lacking MSH2 as manifest by MSI was found in 7 of 11 cases studied. Mutations of the p53 gene in these 43 samples were also investigated by direct sequencing of full-length p53 cDNA. Mutations of p53 were found in 6 of 43 cases, including 5 of the 14 (35.7%) cases that did not express MSH2 protein. In contrast, mutation of p53 was only found in 1 of 29 (3.4%) cases with normal MSH2 protein expression (χ2 = 5.720, P < .02). These results suggest that abnormalities of DNA mismatch repair due to defective MSH2 expression could play a key role in leukemogenesis, in particular in AML arising in elderly patients or secondary to previous chemotherapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“several lines of evidence support a role of impaired DNA mismatch repair (MMR) in leukemogenesis23–25.”
From Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia (2015) · cites this paper as [24]
Citations
Cites
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R. A., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J. E., Kane, M., & Kolodner, R. D. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,884
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Ionov, Y., Peinado, M. A., Malkhosyan, S. R., Shibata, D. K., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,691
Grimwade, D. J., Walker, H., Oliver, F., Wheatley, K., Harrison, C. J., Harrison, G., Rees, J., Hann, I. M., Stevens, R., Burnett, A. K., et al. (1998) · Blood · doi:10.1182/blood.v92.7.2322 · Cited by 2,649
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
MISMATCH REPAIR IN REPLICATION FIDELITY, GENETIC RECOMBINATION, AND CANCER BIOLOGY
Modrich, P. L., & Lahue, R. S. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.000533 · Cited by 1,510
Leith, C. P., Kopecky, K. J., Godwin, J. E., McConnell, T. S., Slovak, M. L., Chen, I.-M., Head, D. R., Appelbaum, F. R., & Willman, C. L. (1997) · Blood · doi:10.1182/blood.v89.9.3323 · Cited by 859
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability
Liu, B., Nicolaides, N. C., Markowitz, S. D., Willson, J. K. V., Parsons, R. E., Jen, J., Papadopolous, N., Peltomäki, P., de la Chapelle, A., Hamilton, S. R., et al. (1995) · Nature Genetics · doi:10.1038/ng0195-48 · Cited by 801
p53: oncogene or anti-oncogene?Preprint
Lane, D. P., & Benchimol, S. (1990) · Genes & Development · doi:10.1101/gad.4.1.1 · Cited by 796
Cited by
Sorted by citations
p53: traffic cop at the crossroads of DNA repair and recombination
Sengupta, S., & Harris, C. C. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1546 · Cited by 544
Mechanisms of therapy-related carcinogenesis
Allan, J. M., & Travis, L. B. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1749 · Cited by 277
Tumor suppressor genes in normal and malignant hematopoiesis
Krug, U. O., Ganser, A., & Koeffler, H. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205322 · Cited by 232
Therapy-Related Myelodysplasia and Acute Myeloid Leukemia
Bhatia, R. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2013.09.013 · Cited by 220
Seedhouse, C., Bainton, R. D., Lewis, M. D., Harding, A., Russell, N. H., & Das-Gupta, E. P. (2002) · Blood · doi:10.1182/blood-2002-04-1152 · Cited by 182
Self-citationDNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias.
Leone, G. G. M., Teofili, L., Voso, M. T., & Lübbert, M. (2002) · PubMed · Cited by 167
Seedhouse, C., Faulkner, R. D., Ashraf, N., Das-Gupta, E. P., & Russell, N. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0372 · Cited by 164
Self-citationSmith, M. T., Wang, Y., Kane, E. V., Rollinson, S. J., Wiemels, J. L., Roman, E., Roddam, P. L., Cartwright, R. A., & Morgan, G. J. (2001) · Blood · doi:10.1182/blood.v97.5.1422 · Cited by 145
TP53 in hematological cancer: Low incidence of mutations with significant clinical relevance
PELLER, S., & Rotter, V. (2003) · Human Mutation · doi:10.1002/humu.10190 · Cited by 141
Therapy Related Leukemias: Susceptibility, Prevention and Treatment
Leone, G. G. M., Voso, M. T., Sica, S., Roberta Morosetti, A., & Pagano, L. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109057981 · Cited by 132
Diouf, B., Cheng, Q., Krynetskaia, N. F., Yang, W., Cheok, M., Pei, D., Fan, Y., Cheng, C., Krynetskiy, E. Y., Geng, H., et al. (2011) · Nature Medicine · doi:10.1038/nm.2430 · Cited by 129
Will, B., Vogler, T. O., Narayanagari, S., Bartholdy, B., Todorova, T. I., da Silva Ferreira, M., Chen, J., Yu, Y., Mayer, J., Barreyro, L., et al. (2015) · Nature Medicine · doi:10.1038/nm.3936 · Cited by 127
RAD51, genomic stability, and tumorigenesis
Richardson, C. A. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.08.009 · Cited by 118
Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS
Leone, G. G. M., Voso, M. T., Teofili, L., & Lübbert, M. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00207-9 · Cited by 112
The Difficult Problem of Acute Myeloid Leukemia in the Older Adult
Stone, R. M. (2002) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.6.363 · Cited by 97
Repopulating defect of mismatch repair–deficient hematopoietic stem cells
Reese, J., Liu, L., & Gerson, S. L. (2003) · Blood · doi:10.1182/blood-2002-10-3035 · Cited by 89
Esposito, M. T., & So, C. W. E. (2014) · Chromosoma · doi:10.1007/s00412-014-0482-9 · Cited by 88
DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy
de Almeida, L. C., Calil, F. A., Machado‐Neto, J. A., & Costa-Lotufo, L. V. (2020) · Cancer Genetics · doi:10.1016/j.cancergen.2020.12.002 · Cited by 88
Rund, D. G., Krichevsky, S., Cohen, S. B., Goldschmidt, N., Kedmi, M., Malik, E., Gural, A., Shafran‐Tikva, S., Ben‐Neriah, S., & Ben‐Yehuda, D. (2005) · Leukemia · doi:10.1038/sj.leu.2403947 · Cited by 80
Advances in the understanding of susceptibility to treatment‐related acute myeloid leukaemia
Seedhouse, C., & Russell, N. H. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06613.x · Cited by 79
Self-citationWorrillow, L. J., Travis, L. B., Smith, A. G., Rollinson, S. J., Smith, A. J. P., Wild, C. P., Holowaty, E. J., Kohler, B., Wiklund, T. A., Pukkala, ., et al. (2003) · PubMed · doi:10.25405/ncl.34299504 · Cited by 76
Morton, L. M., Saber, W., Baker, K. S., Barrett, A. J., Bhatia, S., Engels, E. A., Gadalla, S. M., Kleiner, D. E., Pavletic, S. Z., & Burns, L. J. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.09.005 · Cited by 68
Scarisbrick, J. J., Mitchell, T. J., Calonje, E. J., Orchard, G. E., Russell‐Jones, R., & Whittaker, S. J. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12496.x · Cited by 57
Bucci, B., D’Agnano, I., Amendola, D., Citti, A., Raza, G. H., Miceli, R., Paula, U. D., Marchese, R., Albini, S., Felsani, A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1582 · Cited by 57
Xinarianos, G., Liloglou, T., Prime, W., Maloney, P. J., Callaghan, J., Fielding, P., Gosney, J. R., & Field, J. K. (2000) · PubMed · Cited by 56
Reduced expression of human mismatch repair genes in adult T-cell leukemia
Morimoto, H., Tsukada, J., Kominato, Y., & Tanaka, Y. (2005) · American Journal of Hematology · doi:10.1002/ajh.20259 · Cited by 54
Seedhouse, C., Das-Gupta, E. P., & Russell, N. H. (2003) · Leukemia · doi:10.1038/sj.leu.2402747 · Cited by 54
Self-citationSheikhha, M. H., Tobal, K., & Yin, A. L. J. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03458.x · Cited by 53
Casorelli, I. (2003) · DNA repair · doi:10.1016/s1568-7864(03)00020-x · Cited by 52
Matheson, E. C. (2003) · Carcinogenesis · doi:10.1093/carcin/24.1.31 · Cited by 53
Liso, V., Albano, F., Pastore, D., Carluccio, P., Mele, G., Lamacchia, M., Mestice, A., & Specchia, G. (2000) · PubMed · Cited by 51
Subsequent Malignant Neoplasms after Hematopoietic Cell Transplantation
Socié, G., Baker, K. S., & Bhatia, R. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2011.10.005 · Cited by 51
The challenge of acute myeloid leukemia in older patients
Sekeres, M. A., & Stone, R. M. (2002) · Current Opinion in Oncology · doi:10.1097/00001622-200201000-00005 · Cited by 50
Yan, W., Xu, L., Sun, Z., Lin, Y., Zhang, W., Chen, J., Hu, S., & Shen, B. (2015) · Oncotarget · doi:10.18632/oncotarget.4459 · Cited by 48
Microsatellite instability occurs in defined subsets of patients with acute myeloblastic leukaemia
Das-Gupta, E. P., Seedhouse, C., & Russell, N. H. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02920.x · Cited by 48
Self-citationMismatch repair deficiency in hematological malignancies with microsatellite instability
Gu, L., Cline-Brown, B., Zhang, F., Qiu, L., & Li, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205695 · Cited by 46
Is there an upper age limit for bone marrow transplantation?
Popplewell, L., & Forman, S. (2002) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703382 · Cited by 42
Bhatia, R. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0659 · Cited by 41
Linet, M. S., Devesa, S. S., & Morgan, G. J. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195149616.003.0044 · Cited by 39
Kenyon, J. D., Fu, P., Lingas, K. T., Thomas, E. A., Saurastri, A., Guasch, G. L. S., Wald, D. N., & Gerson, S. L. (2012) · Blood · doi:10.1182/blood-2011-12-401950 · Cited by 37
Mismatch repair defects as a cause of resistance to cytotoxic drugs
Irving, J. A. E., & Hall, A. G. (2001) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.1.1.149 · Cited by 37
Rahimian, E., Amini, A., Alikarami, F., Pezeshki, S. M. S., Saki, N., & Safa, M. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102951 · Cited by 35
Rigter, L. S., Snæbjörnsson, P., Rosenberg, E. H., Atmodimedjo, P. N., Aleman, B. M. P., ten Hoeve, J., Geurts-Giele, W. R. R., PALGA group, van Ravesteyn, T. W., Hoeksel, J., et al. (2016) · Gut · doi:10.1136/gutjnl-2016-312608 · Cited by 34
Degadration of mismatch repair hMutSα heterodimer by the ubiquitin‐proteasome pathway
Hernandez-Pigeon, H., Laurent, G., Humbert, O., Salles, B., & Lautier, D. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00181-4 · Cited by 33
Allogeneic hematopoietic stem cell transplantation in the elderly
Shapira, M. Y., Tsirigotis, P. D., Resnick, I. B., Or, R., Abdul-Hai, A., & Slavin, S. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.01.004 · Cited by 32
Pallis, M., Grundy, M. A., Turzanski, J., Kofler, R., & Russell, N. H. (2001) · Blood · doi:10.1182/blood.v98.2.405 · Cited by 30
Self-citationTentori, L., Portarena, I., Bonmassar, E., & Graziani, G. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400832 · Cited by 30
Mao, G., Yuan, F., Absher, K., Jennings, C. D., Howard, D. S., Jordan, C. T., & Gu, L. (2008) · Cell Research · doi:10.1038/cr.2008.14 · Cited by 43
Worrillow, L. J., & Allan, J. M. (2005) · Oncogene · doi:10.1038/sj.onc.1209208 · Cited by 29
Humbert, O., Hermine, T., Hernandez, H., Bouget, T., Sèlves, J., Laurent, G., Salles, B., & Lautier, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103451200 · Cited by 27
Onda, M., Nakamura, I., Suzuki, S., Takenoshita, S., Brogren, C., Stampanoni, S., Li, D., & Rampino, N. J. (2001) · PubMed · Cited by 27
Xinarianos, G., Liloglou, T., Prime, W., Sourvinos, G., Karachristos, A., Gosney, J. R., Spandidos, D. A., & Field, J. K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10598 · Cited by 25
Fonseca, F. L., Ana, A. V. S., Bendit, I., Arias, V., Costa, L. J., Pinhal, A. A., & del Giglio, A. (2004) · Breast Cancer Research · doi:10.1186/bcr950 · Cited by 24
Scott, S. A., Kimura, T., Ichinohasama, R., Bergen, S., Magliocco, A. M., Reimer, C. L., Kerviche, A., Sheridan, D. P., & DeCoteau, J. F. (2002) · Leukemia Research · doi:10.1016/s0145-2126(02)00078-4 · Cited by 24
Lowsky, R., Magliocco, A. M., Ichinohasama, R., Reitmair, A. H., Scott, S. A., Henry, M., Kadin, M. E., & DeCoteau, J. F. (2000) · Blood · doi:10.1182/blood.v95.5.1767.005k07_1767_1772 · Cited by 24
Kiss, T. L., Sabry, W., Lazarus, H. M., & Lipton, J. H. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705747 · Cited by 22
Targeting critical regions in genomic DNA with AT-specific anticancer drugs
WOYNAROWSKI, J. M. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00093-5 · Cited by 21
Fordham, S. E., Matheson, E. C., Scott, K. E., Irving, J. A. E., & Allan, J. M. (2011) · Leukemia · doi:10.1038/leu.2011.38 · Cited by 20
Sanz-Vaqué, L., Colomer, D., Bosch, F., López‐Guillermo, A., Dreyling, M. H., Bosch, F., Montserrat, E., & Campo, E. (2001) · PubMed · Cited by 19
Faulkner, R. D., Seedhouse, C., Das-Gupta, E. P., & Russell, N. H. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04750.x · Cited by 17
Self-citationTentori, L., Vernole, P., Lacal, P. M., Madaio, R., Portarena, I., Levati, L., Balduzzi, A., Turriziani, M., Dande, P., Gold, B. I., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401842 · Cited by 17
William, B. M., & Lima, M. J. G. D. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0076-x · Cited by 16
Steffen, L. S., Bacher, J., Peng, Y., Le, P. N., Ding, L.-H., Genik, P. C., Ray, F. A., Bedford, J. S., Fallgren, C. M., Bailey, S. M., et al. (2012) · Mutagenesis · doi:10.1093/mutage/ges055 · Cited by 16
Second Malignancy Risk After Treatment of Hodgkin Lymphoma
Hodgson, D. C., & van Leeuwen, F. E. (2014) · Hematologic malignancies · doi:10.1007/978-3-319-12505-3_24 · Cited by 14
Allelotype analysis of the myelodysplastic syndrome
Xie, D., Hofmann, W.-K., Mori, N., Cw, M., Hoelzer, D. T., & Koeffler, H. (2000) · Leukemia · doi:10.1038/sj.leu.2401717 · Cited by 14
Bret, C., Viziteu, E., Kassambara, A., & Moreaux, J. (2016) · Expert Review of Hematology · doi:10.1586/17474086.2016.1141673 · Cited by 13
The Role of Genomic Instability in the Development of Human Cancer
Coleman, W. B., & Tsongalis, G. J. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-125-1_6 · Cited by 14
Msh2 Deficiency Attenuates But Does Not Abolish Thiopurine Hematopoietic Toxicity in Msh2-- Mice
Krynetskaia, N. F., Brenner, T. L., Krynetski, E. Y., Du, W., Panetta, J. C., Pui, C., & Evans, W. E. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.2.456 · Cited by 12
Rennicke, A., Voigt, W., Mueller, T., Fruehauf, A., Schmoll, H., Beyer, C., & Dempke, W. C. M. (2005) · PubMed · Cited by 12
DNA repair mechanisms and acute myeloblastic leukemia
Das-Gupta, E. P., Seedhouse, C., & Russell, N. H. (2000) · Hematological Oncology · doi:10.1002/1099-1069(200009)18:3 · Cited by 11
Self-citationOlder adults with acute myeloid leukemia
Sekeres, M. A., & Stone, R. M. (2002) · Current Oncology Reports · doi:10.1007/s11912-002-0034-y · Cited by 11
Rapid and Sensitive Detection of Mycobacterium DNA Using Cepheid SmartCycler® and Tube Lysis System
Jones, M., Alland, D., Marras, S. A. E., El-Hajj, H. H., Taylor, M. T., & McMillan, W. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.10.1917 · Cited by 11
Microsatellite analysis in acute myeloid leukaemia evolving from myelodysplastic syndrome
Olipitz, W., Tilz, G. P., Beham‐Schmid, C., Eibinger, C., Kerzina, P., & Sill, H. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02497.x · Cited by 10
Korabiowska, M., Viehöver, M., Schlott, T., Berger, H., Droese, M., & Brinck, U. (2001) · Archives of Dermatological Research · doi:10.1007/s004030100220 · Cited by 9
Sasaki, O., Meguro, K., Tohmiya, Y., Funato, T., Shibahara, S., & Sasaki, T. (2002) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.196.193 · Cited by 8
Das-Gupta, E. P., & Russell, N. H. (2000) · Blood · doi:10.1182/blood.v96.5.2002 · Cited by 8
Self-citationThe Absence of Msh2 Alters Abelson Virus Pre-B-Cell Transformation by Influencing p53 Mutation
Jenab-Wolcott, J., Rodriguez-Correa, D. T., Reitmair, A. H., Mak, T. W., & Rosenberg, N. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8373-8381.2000 · Cited by 8
Mismatch repair deficient hematopoietic stem cells are preleukemic stem cells
Qing, Y., & Gerson, S. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182175 · Cited by 7
Bhatia, S. (2015) · Springer eBooks · doi:10.1007/978-1-4899-7584-3_14 · Cited by 7
Retinal Abnormalities in Newly Diagnosed Adult Acute Myeloid Leukemia
Specchia, G., Albano, F., Guerriero, S., Buquicchio, C., Pomes, L., Pastore, D., Carluccio, P., Noci, N. D., & Liso, V. (2001) · Acta Haematologica · doi:10.1159/000046566 · Cited by 6
Abnormalities in Chromosomes 5 and 7 in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Kendrick, T. S., Buic, D., Fuller, K. A., & Erber, W. N. (2025) · Annals of Laboratory Medicine · doi:10.3343/alm.2024.0477 · Cited by 7
Matheson, E., & Hall, A. G. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg080 · Cited by 5
Evaluation of Temozolomide in Patients with Myelodysplastic Syndrome
Seiter, K. P., Liu, D., Siddiqui, A. D., Lerner, R., Nelson, J., & Ahmed, T. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190310001625683 · Cited by 5
Subsequent Malignant Neoplasms After Hematopoietic Cell Transplantation
Bhatia, R., & Bhatia, R. (2015) · Wiley eBooks · doi:10.1002/9781118416426.ch104 · Cited by 5
Patel, R., Qing, Y., Kennedy, L. H., Yan, Y., Pink, J. J., Aguila, B., Desai, A. B., Gerson, S. L., & Welford, S. M. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0295 · Cited by 4
Chapchap, E. C., Kerbauy, L. N., Esteves, I., Belucci, T. R., Rodrigues, M., Kerbauy, F. R., Santos, F. P. D. S., Ribeiro, A. A. F., & Hamerschlak, N. (2019) · European Journal of Cancer Care · doi:10.1111/ecc.13122 · Cited by 4
Maeck, L., Kohaus, P., Haase, D. T., Hiddemann, W., & Alves, F. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02369.x · Cited by 3
ASPECTOS CLÍNICOS Y EPIDEMIOLÓGICOS DE LA LEUCEMIA MIELOIDE AGUDA EN EL ANCIANO
Roldán, M. T. M., Buchillón, R. J. L., Ramírez, P. H., Llánes, O. M. A., & Monzón, E. R. (2002) · Revista cubana de hematología, inmunología y hemoterapia · Cited by 2
Multidrug Resistance Mechanism of Acute Lymphoblastic Leukemia
Su, Z., Zhu, H., Liu, Y., Yuan, H., Yin, J., & Xu, H. (2011) · InTech eBooks · doi:10.5772/26488 · Cited by 2
Magalhães, M., Oliveira, P. D., Bittencourt, A. L., & Farré, L. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003403 · Cited by 2
Staib, P., Lippl, S., & Spiekermann, K. (2015) · best practice onkologie · doi:10.1007/s11654-015-0247-9 · Cited by 2
Therapy-Related Acute Myelogenous Leukemia
Iwanski, G. B., Thoennissen, N. H., Park, D. J., & Koeffler, H. P. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3764-2_24 · Cited by 2
Belgrader, P., Raisi, F., Joshi, R., Nguyen, P., McMillan, W., Ching, J., Chang, R., & Northrup, M. A. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.10.1929 · Cited by 2
Turzanski, J., Zhu, Y., Pallis, M., & Russell, N. H. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00286-5 · Cited by 2
Self-citationLeukemia Relapse Reconsidered from the Molecular Aspect
Naoe, T., Nakano, Y., & Kiyoi, H. (2000) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190009058504 · Cited by 2
Friedman, D. L. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00062-x · Cited by 2
Second Malignancy Risk After Treatment of Hodgkin Lymphoma
Hodgson, D. C., & van Leeuwen, F. E. (2010) · Springer eBooks · doi:10.1007/978-3-642-12780-9_22 · Cited by 2
Mismatch repair gene promoter methylation and expression in hydatidiform moles
Chen, H., Ye, D.-F., Xie, X., Lü, W., Zhu, C., & Chen, X. (2004) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-004-0665-3 · Cited by 1
The DNA Damage Response, DNA Repair, and AML
Steensma, D. P. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-322-6_5 · Cited by 1
Metadata
- Authors
- Zhu, Y.-M., Das-Gupta, E. P., & Russell, N. H.
- Affiliations
- University of Nottingham (GB)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1999-07-15
- Volume
- 94
- Issue
- 2
- Pages
- 733-740
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2206735890
- Cited by
- 118
- References
- 47
- Citations by year
- 2025: 1 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 3 · 2015: 8 · 2014: 4 · 2013: 3 · 2012: 4
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- microsatellite instability, TP53 mutation, mismatch repair deficiency, therapy-related acute myeloid leukemia, acute lymphoblastic leukemia, loss of heterozygosity, adult leukemia, germline TP53 mutation
- MeSH terms
- Acute Disease, Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, DNA Mutational Analysis, DNA Repair, DNA-Binding Proteins, DNA, Neoplasm, Female, Humans, Karyotyping, Leukemia, Myeloid, Male, Middle Aged, Proto-Oncogene Proteins, RNA, Messenger, RNA, Neoplasm, Leukemia-Lymphoma, Adult T-Cell, Gene Expression Regulation, Leukemic, Genes, p53, DNA, Complementary, Microsatellite Repeats, Reverse Transcriptase Polymerase Chain Reaction, MutS Homolog 2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review